Gelteq expands operations in united states with appointment of adam bendell as president of u.s. operations to scale domestic business

New york, nov. 12, 2024 (globe newswire) -- gelteq limited (nasdaq: gels) (“gelteq” or the “company”), a clinical and science-based company that is focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, announced today that it has expanded its operations in the united states with the appointment of adam bendell as president of u.s. operations.
GELS Ratings Summary
GELS Quant Ranking